Paratek Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
This page contains a Q&A table for Paratek Pharmaceuticals Inc. The ESG rating covers 17 United Nations Sustainable Development Goals including: 'No Poverty', 'Climate Action' and 'Peace, Justice & Strong Institutions'. This SDG rating for Paratek Pharmaceuticals Inc indicates its reporting of the United Nations SDGs.
Paratek Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.2; made up of an environmental score of 2.7, social score of 4.8 and governance score of 2.0.
3.2
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1253 | Stallergenes Greer Ltd | 3.3 | Medium |
| 1253 | Zynerba Pharmaceuticals Inc | 3.3 | Medium |
| 1299 | Paratek Pharmaceuticals Inc | 3.2 | Medium |
| 1299 | Acreage Holdings Inc | 3.2 | Medium |
| 1299 | Advicenne SA | 3.2 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Paratek Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Paratek Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Paratek Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Paratek Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Paratek Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Paratek Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Paratek Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Paratek Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Paratek Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Paratek Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Paratek Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Paratek Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Paratek Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Paratek Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Paratek Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Paratek Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Paratek Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Paratek Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Paratek Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Paratek Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Paratek Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Paratek Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Paratek Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Paratek Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Paratek Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Paratek Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Paratek Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Paratek Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Paratek Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Paratek Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Paratek Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Paratek Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Paratek Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Paratek Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Paratek Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Paratek Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Paratek Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectrum antibiotic for the treatment of adult patients with community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections caused by susceptible pathogens; and SEYSARA, a tetracycline designed for the treatment of moderate to severe acne vulgaris. The company has license and collaboration agreements with Zai Lab (Shanghai) Co., Ltd. and Allergan plc; license agreement with Tufts University to develop and commercialize products for the treatment or prevention of bacterial or microbial diseases, or medical conditions; and contract with Biomedical Advanced Research and Development Authority to support the development of NUZYRA for the treatment of pulmonary anthrax. In addition, it has license agreement with Tetraphase Pharmaceuticals, Inc. to develop, import, and sell the XERAVATM product, which is used for the treatment of complicated intra-abdominal infections caused by bacteria. Paratek Pharmaceuticals, Inc. was founded in 1996 and is headquartered in Boston, Massachusetts.